Category: Abbott
-
UPC Court of Appeal upholds Abbott’s glucose sensor patent: rejects Sibio’s added matter, inventive step attacks
The UPC Court of Appeal has dismissed Sibio’s bid to revoke Abbott’s continuous glucose monitor patent, confirming its own earlier finding from a related injunction case and issuing two headnotes that will guide how the court treats omitted features in future added matter disputes.
-
Malikie Innovations sets sights on medical device segment with latest U.S. complaint targeting Abbott
The heir to the BlackBerry patent portfolio appears to be testing the waters in the multibillion-dollar market for connected medical devices.
-
UPC’s Hague LD grants Abbott two preliminary injunctions, assumes long-arm jurisdiction (Spain) over German defendants, clarifies urgency requirement
The Unified Patent Court’s Hague LD has provided clarifications on long-arm jurisdiction and urgency that have applicabiliy beyond these two cases.
-
Abbott regains key patent from now-settled Dexcom dispute as EWCA issues rare patent revocation reversal
The England & Wales Court of Appeal has reversed a lower court’s decision to revoke a patent asserted in Abbott’s now-settled global patent dispute with Dexcom, handing the continuous glucose monitor device maker another key win.